Wefight

Le 8 décembre dernier, Wefight est entrée en liquidation judiciaire. C'est la fin d'une aventure formidable. Pendant 6 ans, Wefight a accompagné plus de 500 000 patients à travers le monde. Wefight avait pour ambition de rendre le savoir patient accessible à tous. D'abord grâce à Vik, puis avec notre écosystème de solutions. Notamment MedVik, notre interface de télésuivi des patients. Notre modèle de revenu nous a permis de collaborer avec les BUs des plus grands industriels pharmaceutiques à travers le monde, du marketing au commercial, en passant par le RWE et le médical. Mais le contexte économique de 2022/2023 a généré des difficultés, et malgré notre plan de restructuration et le travail colossal de l'équipe, nous n'avons pas réussi à assurer la survie de l'entreprise. Les services de Wefight sont désormais stoppés. Je suis très déçu de n'avoir pas pu mener l'entreprise vers plus de succès. Je remercie nos patients et les associations de patients qui nous ont fait confiance, nos clients avec qui nous avons eu la chance de grandir et de nous déployer à l'international, ainsi que nos partenaires et investisseurs qui nous ont soutenus pendant notre parcours. Enfin, un immense merci à notre équipe exceptionnelle qui a façonné Wefight au fil de ces 6 années. Une équipe talentueuse, internationale et paritaire qui a créé une culture et une entreprise uniques. Les défis que nous avons relevés nous ont renforcés, et je suis optimiste quant aux opportunités futures pour chacun d'entre nous. -- 🇺🇸🇬🇧-- On December 8th this year, Wefight entered judicial liquidation. It marks the end of an incredible journey. For 6 years, Wefight helped over 500,000 patients worldwide. Wefight's ambition was to make patient knowledge available to everyone, starting with Vik, and then with our ecosystem of solutions, as MedVik, our patient monitoring interface. Our revenue model allowed us to collaborate with the business units of the largest pharmaceutical companies worldwide, from marketing to sales, including RWE and medical. However, the economic context of 2022/2023 generated difficulties, and despite our restructuring plan and the enormous effort of the team, we couldn't ensure the company's survival. Wefight's services are now suspended. I am very disappointed not to have been able to lead the company to greater success. I thank our patients and patient associations who trusted us, our clients with whom we had the opportunity to grow and expand internationally, and our partners and investors who supported us during our journey. Finally, thank you to our exceptional team that shaped Wefight over these 6 years. A talented, international, and diverse team that created a unique culture and company. The challenges we faced have strengthened us, and I am optimistic about the future opportunities for each of us.

📣 We're happy to announce that Wefight is now a member of EPHMRA, the leading association for members in the healthcare market research and insights industry.   We're looking forward to sharing best practices, participating in events, and joining conversations about the future of patient research, and the ways to advance the standards for working.   🤝 It's great to be part of this community as we continue in our mission to unveil powerful insights to improve patients' care journey.   If you want to find out more about our patient research activities, reach out to Anthony Barea. #patientempowerment #patientexperience #healthcareinnovation #marketresearch

Aujourd'hui c'est la Journée Mondiale des Lymphomes ! Touchant 750 000 personnes et représentant près de la moitié des cas de cancers du sang, le #lymphome est le sixième cancer le plus fréquent dans le monde. Nous sommes fiers d'accompagner les #patients et leurs proches en France avec Vik Lymphomes, notre compagnon virtuel développé avec le soutien institutionnel d'Incyte. Le Professeur Charles Herbaux a fait partie de l'équipe soignante qui a collaboré avec nous pour développer Vik Lymphomes. Dans cette interview, il nous parle de la maladie et des défis rencontrés par les patients au cours de leur parcours de soins. Il explique également comment les solutions numériques peuvent améliorer leur vie quotidienne.  Vik Lymphomes : ☝️ Répond à toutes les questions en temps réel, 24h/24 et 7j/7. 🗣 Partage des conseils, de l'inspiration quotidienne et des témoignages de patients. ⏰ Aide les patients à suivre leur maladie (comme les symptômes, le traitement, les rappels de rendez-vous, etc.) L'application est disponible ici : https://lnkd.in/epfXiSXv #patientempowerment #lymphoma #healthcareinnovation #bloodcancerawarenessmonth

[🇫🇷 - FR] - Aujourd'hui, c'est la journée mondiale contre la dermatite atopique et l'eczéma. Anthony Barea, notre expert de l'expérience patient, décrypte pour vous les nouveaux défis auxquels doivent faire face les patients qui vivent avec une forme sévère de la maladie, notamment dans l'accès aux dernières innovations thérapeutiques. ----- [🇬🇧 - ENG] - Today is #WorldAtopicEczemaDay! Our patient experience expert, Anthony Barea, takes you through the new challenges facing patients living with a severe form of #atopicdermatitis, particularly in terms of access to the latest therapeutic innovations. The article is in French, but if you'd like to exchange ideas about the topic, send Anthony a message!  #AtopicEczemaDay #patientexperience #patientsfirst #realworlddata  

🛑 Did you know that intensification of therapy by one year can cost 13,390 life-years and $7.3 billion?   In our latest #whitepaper "Tacking therapeutic inertia to boost outcomes", we cover the causes and impacts of therapeutic inertia on #patients and health systems. 🎯 This phenomenon touches chronic disease patients and leads to suboptimal patient outcomes, faster disease progression, increased healthcare costs, and even contributes to preventable deaths in #healthcare systems.   💡 We also explore ways to address therapeutic inertia, highlighting the role of technological tools and #pharma companies in tackling the issue.   Produced in partnership with Reuters Events Pharma, this whitepaper features experts from top pharma and patient organizations. 🤝 A big thank you to all of those involved! 👇 Get your copy now, the link is in the comments section! #Patientempowerment #patientoutcomes #patientengagement #healthcareinnovation #patientcare

🚀 We're happy to announce that Vik Atopic Dermatitis is now available in one more country: Egypt! 🇪🇬 This marks the 10th country where our virtual companion is present. Developed with the support of patients, associations, and healthcare professionals, this latest launch will empower thousands of #patients and loved ones living with #atopicdermatitis. Available in Arabic, Vik AD: ☝️ Provides answers to all questions 24/7 🗣 Shares tips, daily inspiration, and patient testimonials ⏰ Helps patients monitor their illness (such as symptoms, treatment, appointment reminders, etc.).   It's available for free download here 👉  https://lnkd.in/eHTFP72b A shout-out to the teams involved in this project 👏  Adrien Boher, Aurélien H., Clémence Le Dreff, Lynn Khoury, Julie Delorme, Van Kieu, Marie Bidault des Chaumes, Marine Daniel, Laisa Lopes, Maxime Houé, Manon Selves, Jeremy Busca Cynthia Moukarzel #PatientEmpowerment #patientsfirst #healthcareinnovation #ehealth #pharma

🔔 We're happy to announce that Wefight will be at the next European Respiratory Society International Congress in Milan! 🤝 Our Wefighters Anthony Barea, Jérôme Junca, Cynthia Moukarzel, and Roberto Zenga will be on-site! Make sure to stop by our stand to learn more about our ecosystem of digital solutions, and how we empower #patients living with #respiratory diseases with tools to reduce their time spent in clinical inertia. 💡 They'll also be sharing patient-generated #insights from our latest patient research. 📍 Stand K04 🗓️ 9 - 13 September, Milan - Italy   If you're going to be at the event, come say hi or book a meeting with them directly!  #PatientEmpowerment #ERS2023 #healthcareinnovation #patientsfirst #ehealth

🔐 Patient insights' role in shaping strategies within pharma is undeniable. We see it on a daily basis with our partners, who understand the value of accessing patients' unfiltered voices.  🎯 Over the past couple of years, we've gained our partners' trust by conducting patient research in a more effective manner, using innovative methodologies, and collecting invaluable insights that in turn, help shape decisions. That's why we ran a series of online ads to highlight our latest patient #insights on Psoriasis, Atopic Dermatitis, and HER2+ mBC. In less than 8 weeks we reached over 200 000 pharma professionals! The engagement rates were also off the charts!  👏  We're proud to be able to bridge the gap between #pharma and #patients. If you haven't seen them before, you can download our reports here: Psoriasis 👉  https://lnkd.in/ekg4xpMt HER2+ metastatic breast cancer 👉  https://lnkd.in/eaTrnF9N Atopic Dermatitis 👉  https://lnkd.in/eMcPgv2n  Are you ready to unlock the potential of patient insights for your company? Contact Anthony Barea or Lauren Hiribarne! #PatientEmpowerment #patientvoice #healthcareinnovation

🎭 We are excited to announce the launch of our latest feature, Mood, now available on all Vik apps across 15 countries! 💡 This new feature empowers patients to log their daily mood, gaining valuable insights into the factors influencing their emotional well-being. Additionally, they can then track the evolution of their mood through a personalized dashboard.   🔐 Why is this feature so crucial? Patients with chronic disease often feel a significant psychological burden. By seamlessly integrating Mood into our app alongside disease management tools, our goal is to provide comprehensive support for patients' overall well-being.   🚀 By enabling patients to have a holistic view of their health journey, we empower them with the necessary tools to enhance their quality of life and live better with their disease.   We're proud to continuously transform the care journey of chronic disease and cancer patients! 👏 A show of hands goes out to the dedicated Wefighters behind this great release. Adrien Boher, Alison Codron, Antonin VAL, Lucas Tidas, Tristan Voiron, Van Kieu, Fanny Chesa, Maxime THOMAS, Camélia Ah-Lo #PatientEmpowerment #Patientsfirst #healthcareinnovation #ehealth  

🔔 Check out our latest newsletter: 4 key channels to shine a light on your patient insights!   This edition showcases how we helped one of our partners reach 50,000 patients, conduct a survey among 276 #patients, and share the results at 4 European congresses. 🌍   🎯 We deep dive into HERmione, a research on patient preferences and experiences in HER2-positive breast cancer treatment. HERmione unveiled insightful learnings, which led to a multi-channel communications campaign.   Discover the power of patient #insights, read the newsletter here👇   If you’d like to know more about our latest insights and how we can launch patient #research tailored to your needs, contact Anthony Barea and Lauren Hiribarne. #patientempowerment #Patientvoice #healthcareinnovation